Bioventus Inc.
USD8.11
+0.18 (+2.27%)
CEO
Robert E. Claypoole
IPO Date
2021-02-11
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$7.93
Prev. Close
$7.93
Day Low
$7.81
Day High
$8.14
52W Low
$5.81
52W High
$11.25
Market Cap
$0.55B
Volume
1.12M
| 9,000 |
| $0.00 |
| 14 Apr 2026 | Singleton Mark Leonard | SVP & CFO | M-Exempt | Acquired | 13,000 | $0.00 |
| 14 Apr 2026 | Singleton Mark Leonard | SVP & CFO | F-InKind | Disposed | 5,648 | $9.06 |
| 14 Apr 2026 | Singleton Mark Leonard | SVP & CFO | M-Exempt | Disposed | 13,000 | $0.00 |
| 14 Apr 2026 | CHURCH KATRINA J | SVP & Chief Compliance Officer | M-Exempt | Acquired | 4,300 | $0.00 |
| 14 Apr 2026 | CHURCH KATRINA J | SVP & Chief Compliance Officer | F-InKind | Disposed | 1,868 | $9.06 |
| 14 Apr 2026 | CHURCH KATRINA J | SVP & Chief Compliance Officer | M-Exempt | Disposed | 4,300 | $0.00 |
| 14 Apr 2026 | D'Adamio Anthony | SVP & General Counsel | M-Exempt | Acquired | 9,925 | $0.00 |
| 14 Apr 2026 | D'Adamio Anthony | SVP & General Counsel | F-InKind | Disposed | 4,312 | $9.06 |